rhamnogalacturonan
Botanicalexperimental
Pectin is a heteropolysaccharide, a structural polymer contained in the cell walls and middle lamellae of terrestrial plants. The principal chemical component of pectin is galacturonic acid which was isolated and described by Henri Braconnot in 1825. Commercially produced pectin is a white-to-light-brown powder, produced from citrus fruits for use as an edible gelling agent, especially in jams and jellies, dessert fillings, medications, and sweets; as a food stabiliser in fruit juices and milk drinks; and as a source of dietary fiber. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02535663)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPectin ↗
Also known as
- rhamnogalacturonan
- rhamnogalacturonan
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05421793 | N/A | Jun 6, 2022 | NutriLeads B.V. (Wageningen, The Netherlands), Orebro University |
| NCT02957318 | N/A | Sep 1, 2016 | University of Copenhagen |
| NCT02535663 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2014 | Yonsei University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NutriLeads B.V. (Wageningen, The Netherlands) | For profit | 1 | 0 | 1 | 2022 |
| Orebro University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Yonsei University | Academic/Hospital | 1 | 1 | 1 | 2014 |
4 organizations
Page 1 / 1